KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Medtronic (MDT) Shares Repurchased (2016 - 2026)

Medtronic's Shares Repurchased history spans 12 years, with the latest figure at $105.0 million for Q1 2026.

  • For Q1 2026, Shares Repurchased fell 41.99% year-over-year to $105.0 million; the TTM value through Jan 2026 reached $874.0 million, down 80.95%, while the annual FY2025 figure was $3.2 billion, 51.31% up from the prior year.
  • Shares Repurchased for Q1 2026 was $105.0 million at Medtronic, down from $372.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $2.5 billion in Q3 2024 and bottomed at $71.0 million in Q1 2023.
  • The 5-year median for Shares Repurchased is $226.0 million (2023), against an average of $495.2 million.
  • The largest annual shift saw Shares Repurchased skyrocketed 4277.78% in 2022 before it crashed 95.06% in 2025.
  • A 5-year view of Shares Repurchased shows it stood at $141.0 million in 2022, then soared by 60.28% to $226.0 million in 2023, then grew by 27.43% to $288.0 million in 2024, then grew by 29.17% to $372.0 million in 2025, then crashed by 71.77% to $105.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Shares Repurchased are $105.0 million (Q1 2026), $372.0 million (Q4 2025), and $123.0 million (Q3 2025).